270 related articles for article (PubMed ID: 18616531)
1. MLPA and cDNA analysis improves COL4A5 mutation detection in X-linked Alport syndrome.
Hertz JM; Juncker I; Marcussen N
Clin Genet; 2008 Dec; 74(6):522-30. PubMed ID: 18616531
[TBL] [Abstract][Full Text] [Related]
2. Alport syndrome. Molecular genetic aspects.
Hertz JM
Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
[TBL] [Abstract][Full Text] [Related]
3. Detection of mutations in the COL4A5 gene by SSCP in X-linked Alport syndrome.
Hertz JM; Juncker I; Persson U; Matthijs G; Schmidtke J; Petersen MB; Kjeldsen M; Gregersen N
Hum Mutat; 2001 Aug; 18(2):141-8. PubMed ID: 11462238
[TBL] [Abstract][Full Text] [Related]
4. [Application of multiplex ligation-dependent probe amplification in gene diagnosis of X-linked Alport syndrome].
Zhang YQ; Zhao D; Yu LX; Ding J; Wang F
Zhonghua Yi Xue Za Zhi; 2012 Oct; 92(40):2825-9. PubMed ID: 23290210
[TBL] [Abstract][Full Text] [Related]
5. Genetic testing for X-linked Alport syndrome by direct sequencing of COL4A5 cDNA from hair root RNA samples.
Tazón-Vega B; Ars E; Burset M; Santín S; Ruíz P; Fernández-Llama P; Ballarín J; Torra R
Am J Kidney Dis; 2007 Aug; 50(2):257.e1-14. PubMed ID: 17660027
[TBL] [Abstract][Full Text] [Related]
6. Correlation between mRNA expression level of the mutant COL4A5 gene and phenotypes of XLAS females.
Wang Y; Zhang H; Ding J; Wang F
Exp Biol Med (Maywood); 2007 May; 232(5):638-42. PubMed ID: 17463160
[TBL] [Abstract][Full Text] [Related]
7. A two-tier approach to mutation detection in the COL4A5 gene for Alport syndrome.
King K; Flinter FA; Green PM
Hum Mutat; 2006 Oct; 27(10):1061. PubMed ID: 16941480
[TBL] [Abstract][Full Text] [Related]
8. Detection of mutations in the COL4A5 gene by analyzing cDNA of skin fibroblasts.
Wang F; Wang Y; Ding J; Yang J
Kidney Int; 2005 Apr; 67(4):1268-74. PubMed ID: 15780079
[TBL] [Abstract][Full Text] [Related]
9. [Detection of large deletions in X linked Alport syndrome using competitive multiplex fluorescence polymerase chain reaction].
Wang F; Zhang YQ; Ding J; Yu LX
Beijing Da Xue Xue Bao Yi Xue Ban; 2017 Oct; 49(5):760-767. PubMed ID: 29045953
[TBL] [Abstract][Full Text] [Related]
10. Deletion of the 5'exons of COL4A6 is not needed for the development of diffuse leiomyomatosis in patients with Alport syndrome.
Sá MJ; Fieremans N; de Brouwer AP; Sousa R; e Costa FT; Brito MJ; Carvalho F; Rodrigues M; de Sousa FT; Felgueiras J; Neves F; Carvalho A; Ramos U; Vizcaíno JR; Alves S; Carvalho F; Froyen G; Oliveira JP
J Med Genet; 2013 Nov; 50(11):745-53. PubMed ID: 23958657
[TBL] [Abstract][Full Text] [Related]
11. [Collagen alpha5 and alpha2 (IV) chain coexpression: The procedure of choice to diagnose Alport syndrome from skin biopsies].
Patey-Mariaud de Serre N; Noël LH
Ann Pathol; 2008 Jun; 28(3):182-6. PubMed ID: 18706356
[TBL] [Abstract][Full Text] [Related]
12. Severe alport phenotype in a woman with two missense mutations in the same COL4A5 gene and preponderant inactivation of the X chromosome carrying the normal allele.
Guo C; Van Damme B; Vanrenterghem Y; Devriendt K; Cassiman JJ; Marynen P
J Clin Invest; 1995 Apr; 95(4):1832-7. PubMed ID: 7706490
[TBL] [Abstract][Full Text] [Related]
13. Detection of mutations in COL4A5 in patients with Alport syndrome.
Plant KE; Green PM; Vetrie D; Flinter FA
Hum Mutat; 1999; 13(2):124-32. PubMed ID: 10094548
[TBL] [Abstract][Full Text] [Related]
14. [Detection of a novel mutation in COL4A5 gene from a Chinese family with X-linked alport syndrome].
Peng CL; Liang H; Z ou QL; Wang J; Liu CS; Zhang XF; Chen J; Hu SN
Yi Chuan Xue Bao; 2004 Nov; 31(11):1190-5. PubMed ID: 15651669
[TBL] [Abstract][Full Text] [Related]
15. Deletions in the COL4A5 collagen gene in X-linked Alport syndrome. Characterization of the pathological transcripts in nonrenal cells and correlation with disease expression.
Antignac C; Knebelmann B; Drouot L; Gros F; Deschênes G; Hors-Cayla MC; Zhou J; Tryggvason K; Grünfeld JP; Broyer M
J Clin Invest; 1994 Mar; 93(3):1195-207. PubMed ID: 8132760
[TBL] [Abstract][Full Text] [Related]
16. Detection of mutations in the COL4A5 gene in over 90% of male patients with X-linked Alport's syndrome by RT-PCR and direct sequencing.
Inoue Y; Nishio H; Shirakawa T; Nakanishi K; Nakamura H; Sumino K; Nishiyama K; Iijima K; Yoshikawa N
Am J Kidney Dis; 1999 Nov; 34(5):854-62. PubMed ID: 10561141
[TBL] [Abstract][Full Text] [Related]
17. Somatic mosaicism for a mutation of the COL4A5 gene is a cause of mild phenotype male Alport syndrome.
Krol RP; Nozu K; Nakanishi K; Iijima K; Takeshima Y; Fu XJ; Nozu Y; Kaito H; Kanda K; Matsuo M; Yoshikawa N
Nephrol Dial Transplant; 2008 Aug; 23(8):2525-30. PubMed ID: 18332068
[TBL] [Abstract][Full Text] [Related]
18. Deletion mapping in Alport syndrome and Alport syndrome-diffuse leiomyomatosis reveals potential mechanisms of visceral smooth muscle overgrowth.
Thielen BK; Barker DF; Nelson RD; Zhou J; Kren SM; Segal Y
Hum Mutat; 2003 Nov; 22(5):419. PubMed ID: 14517961
[TBL] [Abstract][Full Text] [Related]
19. A case with somatic and germline mosaicism in COL4A5 detected by multiplex ligation-dependent probe amplification in X-linked Alport syndrome.
Aoto Y; Kise T; Nakanishi K; Nagano C; Horinouchi T; Yamamura T; Ishiko S; Sakakibara N; Shima Y; Morisada N; Iijima K; Nozu K
CEN Case Rep; 2020 Nov; 9(4):431-436. PubMed ID: 32621070
[TBL] [Abstract][Full Text] [Related]
20. Clinical and molecular diagnosis of Alport syndrome.
Kashtan CE
Proc Assoc Am Physicians; 1995 Oct; 107(3):306-13. PubMed ID: 8608415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
